ALLIANCE OF MEDICINES FOR IRELAND COMPANY LIMITED BY GUARANTEE

Intent: Engage with relevant stakeholders regarding a new Framework Agreement, highlighting the importance of the generic, biosimilar and off-patent medicines industry and the critical role it plays in delivering affordable and vital medicines for Irish patients.

Methods: Meeting

Intent: Inform Sean Kelly MEP, Billy Kelleher MEP, and EU Commissioner McGrath of the implications of the EU's Urban Waste Water Treatment Directive ,the Commission's commitment to undertake a further impact assessment, present further data provided by Medicines for Europe, and seek a meeting regarding the same.

Methods: Email

Intent: Seek clarity from the Minister for Housing, James Browne TD, regarding key elements of the planned implementation of the EU's UWWTD, and note the impact the Directive will impose on the pharmaceutical sector.

Methods: Email

Intent: Inform the Minister for Health and An Taoiseach of the priorities of Medicines for Europe, which call on the EU to accelerate pharmaceutical legislation to improve access to medicines, avoid costly intellectual property extensions, and address environmental rules that risk driving up prices and causing shortages, while also urging stronger support for critical medicine production through funding, improved tendering rules, and trade policy

Methods: Email

Intent: Inform Deputy David Cullinane of the EU's Urban Waste Water Treatment Directive and its proposed EPR scheme, while also highlighting the associated impacts of the Directive on patient access to affordable medicines, and seeking a meeting to discuss the same.

Methods: Email

Intent: Inform Deputy Martin Daly of the EU's Urban Waste Water Treatment Directive and its proposed EPR scheme, while also highlighting the associated impacts of the Directive on patient access to affordable medicines, and seeking a meeting to discuss the same.

Methods: Email, Meeting

Intent: Seek support from Irish Members of the European Parliament for Amendment 1 of the INI Report on Water Resilience in relation to the UWWTD, and call on the European Commission to carry out a new and comprehensive assessment of the impacts on the pharmaceutical sector.

Methods: Email

Intent: Meeting with the Minister for Health to provide a formal introduction to Medicines for Ireland, highlighting areas of interest for member companies including the negotiation of a new Framework Agreement, the need for patent reform to support timely access to affordable medicines and the implications of the EU Urban Waste Water Treatment Directive on the availability of generic medicines.

Methods: Email, Meeting

Intent: Inform the Minister for Health, Jennifer Carroll MacNeill, of the work of Medicines for Ireland, and highlight the areas of interest for member companies including a new framework agreement, implementation of the Mazars Review recommendations and advancement of digital services within the healthcare industry, while also highlighting the role of generic medicines and seeking a meeting to discuss the same.

Methods: Email

Intent: Invite stakeholders to the MFI breakfast briefing event, 'Digital Solutions for a greener industry', and seek to highlight the urgent need for transition to digital-first communication with healthcare professionals to reduce inefficiencies, environmental impact and rising costs.

Methods: Email, Phone call